Colorectal cancer treatment in elderly patients: A pilot study.

Abstract The incidence of colorectal cancer increases as age progresses. At present, elderly patients have received substandard cancer treatment not supported by “evidence.” Geriatric assessment should be performed preoperatively and selected elderly patients must be offered standard surgical treatment receiving the same complementary therapies as a younger patient. It should be stressed that elderly patients should not be deprived of their decision-making role. In our experience, more than 43% of patients with colorectal cancer are ≥70 years of age, and we believe that they should receive the same type of follow-up. This would allow for the detection and removal of polyps, treatment of malignant tumors, and psychological support similarly to younger patients. Significantly, in our experience, the incidence of reoperation for neoplastic disease is similar in the two patient populations.

Download Full-text

744 FECS EUROCARE pilot study on late outcomes of colorectal cancer treatment

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90772-5 ◽

2003 ◽

Vol 1 (5) ◽

pp. S224

Author(s):

J.P. Gérard ◽

G. Gatta ◽

A. Zurlo ◽

J. Foubert ◽

P. Casali ◽

...

Keyword(s):

Colorectal Cancer ◽

Pilot Study ◽

Cancer Treatment ◽

Colorectal Cancer Treatment

Download Full-text

Elderly patients with colorectal cancer: Treatment modalities and survival in France. National data from the ThInDiT cohort study

European Journal of Cancer ◽

10.1016/j.ejca.2013.12.026 ◽

2014 ◽

Vol 50 (7) ◽

pp. 1276-1283 ◽

Cited By ~ 51

Author(s):

S. Doat ◽

A. Thiébaut ◽

S. Samson ◽

P. Ricordeau ◽

D. Guillemot ◽

...

Keyword(s):

Colorectal Cancer ◽

Cohort Study ◽

Elderly Patients ◽

Cancer Treatment ◽

Treatment Modalities ◽

National Data ◽

Colorectal Cancer Treatment

Download Full-text

Pilot Study of Feasibility to Reduce Lead Times in Colorectal Cancer Treatment in a Moroccan Cancer Center: A Convergent Mixed Method Study

10.21203/rs.3.rs-708538/v1 ◽

2021 ◽

Author(s):

Said Bensbih ◽

Amine Souadka ◽

Otmane Bouksour ◽

Mohamed Dady ◽

Kholoud Houssaini ◽

...

Keyword(s):

Colorectal Cancer ◽

Rectal Cancer ◽

Pilot Study ◽

Cancer Treatment ◽

Low Income ◽

Waiting Times ◽

Cancer Center ◽

Lead Times ◽

The Impact ◽

Colorectal Cancer Treatment

Abstract Background: Short lead time in colorectal cancer treatment is important to improve patient outcomes. This study aimed to explore factors associated with longer lead times between the first consultation and the therapeutic decision, and between the first consultation and the treatment initiation.Results: 83 patients were included in the quantitative analysis. The median T1 duration was 16.53 days, a delay statistically associated with younger age, low-income patients, rectal cancer, and radiotherapy as first treatment. The median T2 duration was 45.36 days. Basic medical insurance and rectal cancer were statistically associated with these delays. In-depth interviews confirmed the impact of the type of medical coverage on the lengthening of the delays. Radiotherapy and the occasional unavailability of equipment were also noted. The objectives set to decrease the two waiting times would be achievable through increased coordination between the different stakeholders and optimization of the care procedures all along, with an effective and efficient hospital supply chain enhanced by a digital orientation.Conclusion: In this pilot study performed in a low-mid income country, the main reasons for delays in the treatment of colorectal cancer were the patient's low socio-economic level and rectal cancer. Increasing coordination and adapted procedures may improve these results.

Download Full-text